Search

Your search keyword '"Hansen, Thomas V.O."' showing total 98 results

Search Constraints

Start Over You searched for: Author "Hansen, Thomas V.O." Remove constraint Author: "Hansen, Thomas V.O."
98 results on '"Hansen, Thomas V.O."'

Search Results

1. Large-scale application of ClinGen-InSiGHT APC-specific ACMG/AMP variant classification criteria leads to substantial reduction in VUS

2. Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

3. Male with an apparently normal phenotype carrying a BRCA1 exon 20 duplication in trans to a BRCA1 frameshift variant

4. Supplementary Table 2 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

5. Supplementary Tables 1-4 from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

6. Supplementary Table 3 from Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

7. Data from Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

8. Data from Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

9. Supplementary Methods, Tables 1-3, Figure 1 from Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

11. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

12. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

13. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

14. Classification of msh6 variants of uncertain significance using functional assays

16. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high frequency of cancer prone syndromes

17. Ovarian and Breast Cancer Risks Associated with Pathogenic Variants in RAD51C and RAD51D

18. A rare missense variant in APC interrupts splicing and causes AFAP in two Danish families

19. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

20. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

23. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

24. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1and BRCA2compared with those harboring protein truncating variants

25. Molecular subtyping of breast cancer improves identification of both high and low risk patients

26. Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group

29. Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

31. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

32. Association of the leucine-7 to proline-7 variation in the signal sequence of neuropeptide Y with major depression

33. Characteristics of the Danish families with multiple endocrine neoplasia type 1

34. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

36. Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

38. Characteristics of the Danish families with multiple endocrine neoplasia type 1

42. A distal Sp 1-element is necessary for maximal activity of the human gastrin gene promoter

48. Dwarfism and Impaired Gut Development in Insulin-Like Growth Factor II mRNA-Binding Protein 1-Deficient Mice.

49. KCl and forskolin synergistically up-regulate cholecystokinin gene expression via coordinate activation of CREB and the co-activator CBP.

50. IMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2mRNA Decay in Cancer and Development

Catalog

Books, media, physical & digital resources